4//SEC Filing
Morgan Wayne David III 4
Accession 0001209191-10-044029
CIK 0001034088other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 2:38 PM ET
Size
14.2 KB
Accession
0001209191-10-044029
Insider Transaction Report
Form 4
ECLIPSYS CORPECLP
Morgan Wayne David III
Interim CFO
Transactions
- Disposition to Issuer
Stock Option
2010-08-24−23,333→ 0 totalExercise: $17.03→ Common Stock (23,333 underlying) - Disposition to Issuer
Stock Option
2010-08-24−20,000→ 0 totalExercise: $23.10→ Common Stock (20,000 underlying) - Disposition to Issuer
Common Stock
2010-08-24−11,075→ 0 total - Disposition to Issuer
Stock Option
2010-08-24−6,250→ 0 totalExercise: $13.79→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]As the transaction was fully described in the joint proxy statement dated July 14, 2010, as filed with the SEC, each Issuer share was converted into 1.2 shares of common stock of Allscripts Healthcare Solutions, Inc. pursuant to a merger of Issuer with a wholly-owned subsidiary of Allscripts. Shares that were converted included 4,829 shares of Issuer unvested restricted stock that will be subject to the same terms as specified in the original grant. Disposition by Reporting Person was approved by Issuer board of directors.
- [F2]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 10,000 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F3]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 2,735 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
- [F4]In connection with the merger described above, each Issuer option was converted into an option to purchase Allscript common stock equal to 1.2 times the number of Issuer shares subject of the Issuer option and the exercise price was adjusted by dividing the Issuer exercise price by the 1.2 ratio in accordance with the merger agreement. Expiration date remains as originally set. Reporting Person's options were vested as to 5,834 Issuer shares. Vesting of the option with respect to the balance of shares will be as specified in the option documents. Disposition by Reporting Person was approved by Issuer board of directors.
Documents
Issuer
ECLIPSYS CORP
CIK 0001034088
Entity typeother
Related Parties
1- filerCIK 0001454322
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 2:38 PM ET
- Size
- 14.2 KB